Coloplast (COLO-B.CO) Financial Analysis & Valuation | Quarter Chart
Coloplast (COLO-B.CO)
COLO-B.COPrice: $88.18
Fair Value: 🔒
🔒score
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides os... more
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United St... more
Description
Shares
| Market Cap | $19.88B | Exchange | CPH |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | DK | CEO | Lars Soren Rasmussen |
| IPO Date | 2000-01-02 | CAGR | 0.07% |
| Employees | 16,741 | Website | www.coloplast.com |
| Div. Yield | 45.54% | Payout Ratio | 1.22% |
| Buy Back Yield | — | Total Yield | 45.54% |
COLO-B.CO chart loading...
Fundamentals
Technicals
| Enterprise Value | $157.83B | P/E Ratio | 34.8 |
| Forward P/E | 15.11 | PEG Ratio | 0.67 |
| P/S Ratio | 0.4 | P/B Ratio | 0.66 |
| P/CF Ratio | 1.68 | P/FCF Ratio | 2.17 |
| EPS | $2.53 | EPS Growth 1Y | -18.73% |
| EPS Growth 3Y | -19.42% | EPS Growth 5Y | -2.37% |
| Revenue Growth 1Y | 5.95% | Gross Margin | 0.68% |
| Operating Margin | 0.27% | Profit Margin | 0.15% |
| ROE | 0.24% | ROA | 0.09% |
| ROCE | 0.2% | Current Ratio | 1 |
| Quick Ratio | 0.64 | Cash Ratio | 0.07 |
| Debt/Equity | 1.47 | Interest Coverage | 6.06 |
| Altman Z Score | 3.94 | Piotroski Score | 7 |